Blocking SCoR2 Could Halt Fat Production and Lower Cholesterol
A Cleveland team identified SCoR2, an enzyme that removes nitric oxide from proteins controlling fat storage and production. In mice, inhibiting SCoR2 prevented weight gain, reduced liver damage, and lowered cholesterol, suggesting a first‑in‑class drug could treat obesity and cardiovascular disease, with clinical trials anticipated in about 18 months.